AMONDYS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Amondys, and what generic alternatives are available?
Amondys is a drug marketed by Sarepta Theraps Inc and is included in one NDA. There are five patents protecting this drug.
The generic ingredient in AMONDYS is casimersen. One supplier is listed for this compound. Additional details are available on the casimersen profile page.
DrugPatentWatch® Generic Entry Outlook for Amondys
Indicators of Generic Entry
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AMONDYS?
- What are the global sales for AMONDYS?
- What is Average Wholesale Price for AMONDYS?
Summary for AMONDYS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for AMONDYS |
| DailyMed Link: | AMONDYS at DailyMed |
US Patents and Regulatory Information for AMONDYS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sarepta Theraps Inc | AMONDYS 45 | casimersen | SOLUTION;INTRAVENOUS | 213026-001 | Feb 25, 2021 | RX | Yes | Yes | 9,758,783 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sarepta Theraps Inc | AMONDYS 45 | casimersen | SOLUTION;INTRAVENOUS | 213026-001 | Feb 25, 2021 | RX | Yes | Yes | 9,228,187 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Sarepta Theraps Inc | AMONDYS 45 | casimersen | SOLUTION;INTRAVENOUS | 213026-001 | Feb 25, 2021 | RX | Yes | Yes | RE48960 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Sarepta Theraps Inc | AMONDYS 45 | casimersen | SOLUTION;INTRAVENOUS | 213026-001 | Feb 25, 2021 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sarepta Theraps Inc | AMONDYS 45 | casimersen | SOLUTION;INTRAVENOUS | 213026-001 | Feb 25, 2021 | RX | Yes | Yes | 10,781,450 | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
